Injectable Drugs Market - Growth, Trends, and Forecast (2019 - 2024)

The Market is segmented by Molecule Type (Small Molecule and Large Molecule), Drug Class, Application and Geography

Market Snapshot

Injectable Drugs Market - 1
Study Period:

2016-2024

Base Year:

2018

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

11.1%

Key Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

The injectable drugs market is expected to register a CAGR of nearly 11.1% during the forecast period, 2019-2024. The market is segmented by molecule type, drug-class, application, and geography

From the past one era of healthcare, biologics are increasingly becoming the driving forces of the pharmaceutical industry, and prefilled syringes have gained increased acceptance as delivery systems for injectable drugs in the treatment of chronic diseases.

Prefilled syringes are mainly sterilized via autoclaving or by ionizing radiation. Their ease of administration and the greater level of safety have increased the competition among the leading companies of injectable drugs.

With the need for more convenient drug-delivery methods, they are becoming the fastest-growing choices for unit dose medication (minimizing dosing error), in order to reduce the drug waste and increase the product life span.

The prefilled syringes have increased utilization across a wide range of therapeutic areas, such as blood stimulants, therapeutic proteins, and vaccines. With the rapid growth of the emerging markets, there is an increasing demand for patient-friendly parenteral delivery systems.

With the growing list of new compounds under new therapeutic classes, more complex technology is needed, along with higher investments.

The European market is well developed when compared to the US region, due to the presence of big pharmaceutical players, such as Becton-Dickinson, Gerresheimer, and Schott, among others.

The rising focus toward development considerations, such as pistons, barrels, needles, and needle shields, along with the compatibility of the drug product with the barrel contact surface, is crucial for the quality of drug products.

Thus, over the forecast period, a wide expansion of prefilled syringes is expected across the world, This is expected to drive the demand for injectable drugs.

 

Scope of the Report

As per the scope of the report, generic injectable refers to biologics that are used for the treatment of various drugs and has the same active ingredients to that of the branded versions of it, however, the inactive contents of the drugs can be varied.

The injectable drug market is gaining high importance in hospitals and clinics, with an increasing number of biologics, antibody-drug conjugates, and monoclonal antibodies in development, along with several injectable drugs under clinical trials status, globally.

By Molecule Type
Small Molecule
Large Molecule
By Drug Class
Blood Factors
Cytokines
Peptide Hormone
Immunoglobulin
Monoclonal Antibodies (mAbs)
Insulin
Other Drug Classes
By Application
Oncology
Neurology
Cardiovascular Diseases
Autoimmune Diseases
Infectious Diseases
Pain
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

By Molecule Type, Large Molecule has the Highest Share in the Market

The large molecule is dominating the market due to the steady rise of biologics, orphan drugs, and precision medicines across the biopharmaceutical industry. Furthermore, in 2017, the US FDA drug approval hit a record high, in which biologics and gene therapies played a significant part. With the increasing approval rate of biologics, the demand for injectable drugs is expected to rise significantly.

Injectable Drugs Market - 2

To understand key trends, Download Sample Report

North America Region Holds the Largest Market Share of Injectable Drugs Market

North America dominates the Injectable Drugs market, owing to rapid developments in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers. Furthermore, the expansion of different companies to increase their production capacities is also drive the North American injectable drugs market.

Injectable Drugs Market - 3

To understand geography trends, Download Sample Report

Competitive Landscape

North America dominates the Injectable Drugs market, owing to rapid developments in healthcare infrastructure, the presence of major players in the region, huge investments made in the research and development, and increased adoption of oncology-related drugs in hospitals to treat different cancers. Furthermore, the expansion of different companies to increase their production capacities also drives the North American injectable drug market.

Major Players

  1. Novo Nordisk A/S
  2. Amgen Inc.
  3. Baxter
  4. Gilead Sciences Inc.
  5. GlaxoSmithKline PLC

* Complete list of players covered available in the table of contents below

Injectable Drugs Market - 4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising R&D Focus on Development of Biotechnology-Engineered Anti-cancer Drugs

      2. 4.2.2 Rapid Growth in the Usage of Pre-filled Syringes for Biologic Products

      3. 4.2.3 Increased Outsourcing Activities Across Value Chain Expected to Boost Supply of Injectable Products

    3. 4.3 Market Restraints

      1. 4.3.1 High Expenses Associated with Inventory Management

      2. 4.3.2 Stringent Regulatory Requirement for High-end Machinery

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Molecule Type

      1. 5.1.1 Small Molecule

      2. 5.1.2 Large Molecule

    2. 5.2 By Drug Class

      1. 5.2.1 Blood Factors

      2. 5.2.2 Cytokines

      3. 5.2.3 Peptide Hormone

      4. 5.2.4 Immunoglobulin

      5. 5.2.5 Monoclonal Antibodies (mAbs)

      6. 5.2.6 Insulin

      7. 5.2.7 Other Drug Classes

    3. 5.3 By Application

      1. 5.3.1 Oncology

      2. 5.3.2 Neurology

      3. 5.3.3 Cardiovascular Diseases

      4. 5.3.4 Autoimmune Diseases

      5. 5.3.5 Infectious Diseases

      6. 5.3.6 Pain

      7. 5.3.7 Other Applications

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Novo Nordisk A/S

      2. 6.1.2 Amgen Inc.

      3. 6.1.3 Baxter

      4. 6.1.4 Gilead Sciences Inc.

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Merck & Co. Inc.

      8. 6.1.8 Novartis AG

      9. 6.1.9 Pfizer Inc.

      10. 6.1.10 Sanofi

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please Enter a Valid Message!


Complete your payment details below

Shipping & Billing Information

Payment Information